1. Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12: 520-527 doi:10.1093/neuonc/nop066
2. Kleihues P, Cavenee WK, International Agency for Research on Cancer. (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon
3. World Health Organization., International Agency for Research on Cancer. (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, World Health Organization, International Agency for Research on Cancer (2016) WHO classification of tumours of the central nervous system. International Agency For Research On Cancer, Lyon
5. Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS (2015) Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol 17: 1166-1173 doi:10.1093/neuonc/nov069
6. Rogers L, Gilbert M, Vogelbaum MA (2010) Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 99: 393-405 doi:10.1007/s11060-010-0343-1
7. Sun SQ, Hawasli AH, Huang J, Chicoine MR, Kim AH (2015) An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus 38: E3 doi:10.3171/2015.1.FOCUS14757
8. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT, Jr., Barker FG, 2nd (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64: 56-60; discussion 60 doi:10.1227/01.NEU.0000330399.55586.63
9. Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017) Adjuvant radiotherapy for atypical meningiomas. J Neurosurg 126: 1822-1828 doi:10.3171/2016.5.JNS152809
10. Bray DP, Quillin JW, Press RH, Yang Y, Chen Z, Eaton BR, Olson JJ (2021) Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience. Neurosurgery 88: E435-E442 doi:10.1093/neuros/nyaa580
11. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A (2017) Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. World Neurosurg 103: 655-663 doi:10.1016/j.wneu.2017.04.095
12. Hasan S, Young M, Albert T, Shah AH, Okoye C, Bregy A, Lo SS, Ishkanian F, Komotar RJ (2015) The role of adjuvant radiotherapy after gross total resection of atypical meningiomas. World Neurosurg 83: 808-815 doi:10.1016/j.wneu.2014.12.037
13. Pereira BJA, de Almeida AN, Paiva WS, Teixeira MJ, Marie SKN (2019) Impact of radiotherapy in atypical meningioma recurrence: literature review. Neurosurg Rev 42: 631-637 doi:10.1007/s10143-018-0959-8
14. Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, McMillan WG, de Groot JF, Zhang P, Mehta MP (2020) High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539. Int J Radiat Oncol Biol Phys 106: 790-799 doi:10.1016/j.ijrobp.2019.11.028
15. Aboukais R, Zairi F, Lejeune JP, Le Rhun E, Vermandel M, Blond S, Devos P, Reyns N (2015) Grade 2 meningioma and radiosurgery. J Neurosurg 122: 1157-1162 doi:10.3171/2014.9.JNS14233
16. Hardesty DA, Wolf AB, Brachman DG, McBride HL, Youssef E, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N (2013) The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119: 475-481 doi:10.3171/2012.12.JNS12414
17. Helis CA, Hughes RT, Cramer CK, Tatter SB, Laxton AW, Bourland JD, Munley MT, Chan MD (2020) Stereotactic Radiosurgery for Atypical and Anaplastic Meningiomas. World Neurosurg 144: e53-e61 doi:10.1016/j.wneu.2020.07.211
18. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL (2012) Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer 118: 1048-1054 doi:10.1002/cncr.26362
19. Shepard MJ, Xu Z, Kearns K, Li C, Chatrath A, Sheehan K, Sheehan D, Faramand A, Niranjan A, Kano H, Gurewitz J, Bernstein K, Liscak R, Guseynova K, Grills IS, Parzen JS, Cifarelli CP, Rehman AA, Atik A, Bakhsheshian J, Zada G, Chang E, Giannotta S, Speckter H, Wu HM, Kondziolka D, Golfinos JG, Mathieu D, Lee CC, Warnick RE, Lunsford LD, Sheehan JP (2021) Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results From a Multicenter, International Cohort Study. Neurosurgery doi:10.1093/neuros/nyaa553
20. Zhang M, Ho AL, D'Astous M, Pendharkar AV, Choi CY, Thompson PA, Tayag AT, Soltys SG, Gibbs IC, Chang SD (2016) CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas. World Neurosurg 91: 574-581 e571 doi:10.1016/j.wneu.2016.04.019
21. Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170 doi:10.1136/bmj.310.6973.170
22. Barker HE, Paget JT, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15: 409-425 doi:10.1038/nrc3958